Our work shows that PDGFB and mutant IDH synergize to accelerate gliomagenesis in the absence of other mutations, suggesting that mutant IDH and high levels of PDGFB are sufficient to induce glioma. The gene discussed is PDGFB; the disease is central nervous system cancer.